CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Atorvastatin +1 moredrug
Likely dose
Atorvastatin 40 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00756886
NCT00756886N/ACompleted
CompareCT.gov

Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study

University of Alabama at Birmingham·interventional·Posted Sep 22, 2008·Updated Apr 2, 2013

In Brief

A clinical study evaluating Atorvastatin and Placebo for Arrhythmia. Completed, enrolled 73 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if atorvastatin (Lipitor) reduces the occurence of abnormal heart rhythm (atrial arrhythmia) following non cardiac thoracic surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia
CountriesUnited States
CollaboratorsPfizer

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 22, 2008
Enrollment StartSep 1, 2008
Primary CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 17.8 years ago

Interventions

Atorvastatindrug

40 mg QD 7 day continue after procedure for 14 days

Placebodrug

40 mg QD for 7 days prior to surgery, and then continue at same dosage for 14 days after surgery.